Search

everythinglearnresearchcommunity

for

Search:↓

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Adding insulin-like growth factor 1 and bone marrow-derived stem cells to a collagen-chitosan scaffold helps wounds heal faster and regrows hair follicles.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

The new treatment using microneedle patches shows promise for better hair growth in androgenetic alopecia.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Testosterone may influence COVID-19 severity and outcomes.

Tissue engineering could be a future solution for hair loss, but it's currently expensive, complex, and hard to apply in real-world treatments.

Korean Red Ginseng may help protect hair from damage and promote growth.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Non-immune factors play a significant role in alopecia areata.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

CIP/KIP proteins help stop cell division and support hair growth.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Alopecia areata involves immune response and gene changes affecting hair loss.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

New Australian advertising rules improved stem cell marketing practices but further regulation is needed for consumer safety.

Wnt5a may contribute to psoriasis by reducing skin cell growth, blocking skin cell maturation, and increasing inflammation.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Skin RAGE levels are linked to inflammation and cell death.